newsfilter
← Latest News
GlobeNewswire·

AccuStem Sciences Announces Issuance of US Patent for StemPrintER Test for Patients with Breast Cancer

LONDON and PHOENIX, Ariz., Sept. 13, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB:ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today that the US Patent and Trademark Office h